Aflac Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements (Mar. 16, 2017)
Managed Care Weekly Digest
By a News Reporter-Staff News Editor at Managed Care Weekly Digest -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Aflac Inc. (Form DEF 14A) was posted on March 16, 2017.
The SIC code for this company is 6321, Accident and Health Insurance.
The SEC file number is 0001206774-17-000860.
The contact information for this company is 1932 WYNNTON RD, COLUMBUS GA 31999, 7063233431.
Our editors provided additional information about Form DEF 14A: All other filed by non-management definitive proxy statements - typically an annual meeting proxy.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
Leading Texas Trust, Estate, and Probate Litigation Law Firm, Burdette & Rice Announces Trifecta in Texas Rising Stars Super Lawyer Designation
Cno Financial Group, Inc. Files SEC Form 8-K, Current Report (Mar. 21, 2017)
Advisor News
- Global economic growth will moderate as the labor force shrinks
- Estate planning during the great wealth transfer
- Main Street families need trusted financial guidance to navigate the new Trump Accounts
- Are the holidays a good time to have a long-term care conversation?
- Gen X unsure whether they can catch up with retirement saving
More Advisor NewsAnnuity News
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
- Iowa defends Athene pension risk transfer deal in Lockheed Martin lawsuit
- Pension buy-in sales up, PRT sales down in mixed Q3, LIMRA reports
- Life insurance and annuities: Reassuring ‘tired’ clients in 2026
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- New York Life Investments Expands Active ETF Lineup With Launch of NYLI MacKay Muni Allocation ETF (MMMA)
- LTC riders: More education is needed, NAIFA president says
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
- Report Summarizes Kinase Inhibitors Study Findings from Saga University Hospital (Simulation of Perioperative Ibrutinib Withdrawal Using a Population Pharmacokinetic Model and Sparse Clinical Concentration Data): Drugs and Therapies – Kinase Inhibitors
- Flawed Social Security death data puts life insurance benefits at risk
More Life Insurance News